Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Knight Therapeutics Inc

(TSX: GUD.TO)
Add to Portfolio
-0.08 (-1.03%)
as of Nov 15, 2019

Last 7.65
Change -0.08 (-1.03%)
Open 7.75
Prev. Close 7.73
Today's Range
7.63
7.82
52wk Range
7.10
8.88
Volume 261,596
Avg Volume 351,393

Perfomance Comparison

Name Today 3-Month 1-Year
GUD.TO -1.03% -1.92% -8.71%
$TXCX +0.33% +2.74% +12.44%
$TXSC -0.03% +3.51% +11.98%
DJIA +0.80% +4.51% +10.74%
S&P 500 +0.77% +4.76% +14.29%

Key Statistics

Annual EPS 0.15
Dividend Yield N/A
P/E Ratio 50.00
Market Capitalization, $K 1,037,563
Weighted Alpha -7.10
Standard Deviation -0.33
Profit Margin 1.52%
Beta 0.63

Growth Rates

YTD -0.52%
1-Year -9.25%
3-Year -24.26%
5-Year +14.35%

Opinion

Sell Hold Buy

Recent Headlines

Knight Therapeutics Reports Third Quarter 2019 Results

GlobeNewswire via COMTEX - Tue Nov 12, 05:22PM EST
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a Canadian specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2019. All currency amounts are in thousands except for share a(full story)
KHTRF: 5.8918 (+0.1238), GUD.TO: 7.65 (-0.08)

Notice of Knight Therapeutics' Third Quarter 2019

GlobeNewswire via COMTEX - Tue Nov 05, 07:30AM EST
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, will release its third quarter 2019 financial results on Tuesday, November 12, 2019 after market closing. Following the release, (full story)
KHTRF: 5.8918 (+0.1238), GUD.TO: 7.65 (-0.08)

Knight and TherapeuticsMD Announce Filing of New Drug

GlobeNewswire via COMTEX - Wed Oct 30, 05:01PM EDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight") and TherapeuticsMD, Inc. (NASDAQ: TXMD) ("TherapeuticsMD") announced today that Knight's New Drug Submission (NDS) for Joyesta(TM) has been accepted for review by Health Canada. Joye(full story)
KHTRF: 5.8918 (+0.1238), GUD.TO: 7.65 (-0.08), TXMD: 2.74 (-0.01)

Knight Therapeutics and SIFI S.p.A. Announce Approval

GlobeNewswire via COMTEX - Wed Oct 23, 07:00AM EDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, and SIFI S.p.A. ("SIFI"), a prominent Italian Eye Care company, today announced that Health Canada has approved NETILDEX(R) for t(full story)
KHTRF: 5.8918 (+0.1238), GUD.TO: 7.65 (-0.08)

Knight Therapeutics to Acquire Grupo Biotoscana,

GlobeNewswire via COMTEX - Mon Oct 21, 07:00AM EDT
Transformational acquisition establishes Knight as a premiere pan-American (ex-US) specialty pharma company(full story)
KHTRF: 5.8918 (+0.1238), GUD.TO: 7.65 (-0.08)